Deci­bel chief Holtz­man cham­pi­ons Fen­way as the new ‘hood in biotech; Aduro adds 2nd Keytru­da com­bo for can­cer

→ Deci­bel Ther­a­peu­tics CEO Steve Holtz­man isn’t just hop­ing to pi­o­neer new hear­ing drugs at his start­up. The Bio­gen vet is al­so cru­sad­ing to make Fen­way, a Boston neigh­bor­hood just across the Charles Riv­er from Cam­bridge, as the next big biotech hub in the city. To­day he and his fast-grow­ing staff of 50 moved in­to 32,000 square feet of fresh­ly ren­o­vat­ed lab space in Van Ness, lo­cat­ed at 1325 Boyl­ston Street. And he’s urg­ing oth­ers to fol­low his path to a neigh­bor­hood where rents are some­what more rea­son­able.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.